Medical surveillance and long-term prognosis of occupational allergy due to platinum salts

Ameille J, Descatha A (2005) Outcome of occupational asthma. Curr Opin Allergy Clin Immunol 5:125–128

Anonymus (1995) Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 152:1107–1136

Heederik D, Jacobs J, Samadi S, van Rooy F, Portengen L, Houba R (2016) Exposure-response analyses for platinum salt-exposed workers and sensitization: a retrospective cohort study among newly exposed workers using routinely collected surveillance data. J Allergy Clin Immunol 137:922–929

Malo JL, Ghezzo H (2004) Recovery of methacholine responsiveness after end of exposure in occupational asthma. Am J Respir Crit Care Med 169:1304–1307

Merget R, Schultze-Werninghaus G, Bode F, Bergmann EM, Zachgo W, Meier-Sydow J (1991) Quantitative skin prick and bronchial provocation tests with platinum salt. Br J Ind Med 48:830–837

Merget R, Reineke M, Rueckmann A, Bergmann EM, Schultze-Werninghaus G (1994) Nonspecific and specific bronchial responsiveness in occupational asthma caused by platinum salts after allergen avoidance. Am J Respir Crit Care Med 150:1146–1149

Merget R, Schulte A, Gebler A, Breitstadt R, Kulzer R, Berndt ED et al (1999) Outcome of occupational asthma due to platinum salts after transferal to low-exposure areas. Int Arch Occup Environ Health 72:33–39

Merget R, Kulzer R, Dierkes-Globisch A, Breitstadt R, Gebler A, Kniffka A et al (2000) Exposure-effect relationship of platinum salt allergy in a catalyst production plant: conclusions from a 5-year prospective cohort study. J Allergy Clin Immunol 105:364–370

Merget R, Caspari C, Dierkes-Globisch A, Kulzer R, Breitstadt R, Kniffka A et al (2001) Effectiveness of a medical surveillance programme for the prevention of occupational asthma due to platinum salts. A nested case-control study. J Allergy Clin Immunol 107:707–712

Merget R, Jörres RA, Heinze E, Haufs MG, Taeger D, Brüning T (2009) Development of a 1-concentration-4-step dosimeter protocol for methacholine testing. Respir Med 103:607–613

Padoan M, Pozzato V, Simoni M, Zedda L, Milan G, Bononi I et al (2003) Long-term follow-up of toluene diisocyanate-induced asthma. Eur Respir J 21:637–640

Pisati G, Baruffini A, Bernabeo F, Cerri S, Mangili A (2007) Rechallenging subjects with occupational asthma due to toluene diisocyanate (TDI), after long-term removal from exposure. Int Arch Occup Environ Health 80:298–305

Polychronakis I, Thanasias E, Raulf-Heimsoth M, Merget R (2013) Occupational non-immediate type allergic asthma due to ammonium persulfate. Adv Exp Med Biol 755:79–83

Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests European community for steel and coal. Eur Respir J 6(Suppl 16):5–40

Rachiotis G, Savani R, Brant A, MacNeill SJ, Newman Taylor A et al (2007) Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 62:147–152

Rosenberg N, Garnier R, Rousselin X, Mertz R, Gervais P (1987) Clinical and socio-professional fate of isocyanate-induced asthma. Clin Allergy 17:55–61

Tarlo SM, Liss GM (2001) Can medical surveillance measures improve the outcome of occupational asthma? J Allergy Clin Immunol 107:583–585

Vandenplas O, Dressel H, Wilken D, Jamart J, Heederik D, Maestrelli P et al (2011) Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence. Eur Respir J 38:804–811

Vandenplas O, Dressel H, Nowak D, Jamart J (2012) ERS task force on the management of work-related asthma. What is the optimal management option for occupational asthma? Eur Respir Rev 21:97–104

Wilken D, Baur X, Barbinova L, Preisser A, Meijer E, Rooyackers J et al (2012) What are the benefits of medical screening and surveillance? Eur Respir Rev 21(124):105–111